Study Stopped
Project during development was discontinued before the enrollment of participants
Exercise Training Study Before Bariatric Surgery
BaSE
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this clinical trial is to figure out if 8 weeks of walking exercise before bariatric surgery improves risk factors for diabetes and other markers of health. This is important as it may help reduce complications after surgery, improve health markers and increase physical activity levels after surgery (which is an important marker of maintaining bariatric weight loss). The main question that this study is trying to answer is whether walking improves a risk factor for type 2 diabetes called insulin sensitivity (how well your body is able to use glucose). Adults planning to have bariatric surgery will be recruited from the Charlottesville VA area. Before they have their surgery, participants will be randomly assigned (like flipping a coin) to a group that participates in 8 weeks of walking on a treadmill (2-3 times a week) or a group that does their normal care before bariatric surgery. Researchers will compare the effects of walking before bariatric surgery on:
- Insulin sensitivity (diabetes risk factor)
- Health of blood vessels
- Rate of complications after surgery
- Weight
- Body Fat
- Fitness level
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2025
CompletedJune 14, 2024
June 1, 2024
6 months
January 18, 2024
June 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Insulin sensitivity
Insulin sensitivity measured via the hyperinsulinemic-euglycemic clamp
Change from baseline to after surgery (12 weeks)
Secondary Outcomes (19)
Surgical outcomes - readmission within 30 days of surgery
within 30 days
Surgical outcomes - IV treatment as an outpatient
Change from baseline to after surgery (12 weeks)
Surgical outcomes - emergency department visits
Change from baseline to after surgery (12 weeks)
Surgical outcomes - time of surgery
Intraoperative
Surgical outcomes - length of stay after surgery completion
Change from baseline to after surgery (12 weeks)
- +14 more secondary outcomes
Study Arms (2)
Exercise Group (EX-group)
EXPERIMENTALThe EX-group will complete 8 weeks of supervised aerobic exercise training. The EX-group will also continue normal care with bariatric doctors and nurses along with the exercise intervention.
Standard Care Only Group (SC-group)
NO INTERVENTIONThe SC-group will only complete the orientation visit and testing visits. The participants that are randomized to this group will continue normal care with bariatric doctors and nurses. They will participate in study assessment visits only.
Interventions
Previously sedentary adults awaiting bariatric surgery will be randomized to either an Exercise group (EX-group) or Standard care only group (SC-group) for 8 weeks. Outcome visits will occur before the exercise intervention, after the exercise intervention, and after surgery
Eligibility Criteria
You may qualify if:
- Considered sedentary based on self-reported inactivity of \< 2-3 x/week of MVPA within previous 3 months before enrollment.
- Able to walk without use of assistive device, such as cane or walker for ≥ 10 minutes.
- Surgery approved within 6-9 months of initial visit.
- Signed approval from study physician (Dr. Catherine W. Varney; Medical PI of study) that participant is capable to participate.
- Willingness to accept group randomization assignment.
You may not qualify if:
- Any serious medical conditions, such as cancer; history cardiovascular disease of stroke, heart attack, or heart failure; type 1 diabetes mellitus; severe psychiatric illness (such as severe depression); kidney disease.
- Autoimmune diseases such as lupus, multiple sclerosis, Graves' disease, or rheumatoid arthritis.
- HIV or tuberculosis.
- Currently taking medications that lead to significant weight loss (e.g., semaglutide; tirzepatide, etc).
- Resting SBP \> 150 mmHg, DBP \> 100 mmHg.
- Current pregnancy or plans to become pregnant during intervention.
- Plans to be away from the Charlottesville, VA area for \> 1 week during intervention or plans of relocating during the intervention.
- Any medical or health condition (e.g., musculoskeletal, orthopedic, or neurological conditions) that is contraindicated for safe exercise testing and training.
- Previous weight-loss surgeries or revisions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia
Charlottesville, Virginia, 22902, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Randomization will be completely random and will only be known by biostatistician and study coordinator in department but not on study to retain true randomization unaffected by study team.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 18, 2024
First Posted
February 23, 2024
Study Start
July 1, 2024
Primary Completion
January 1, 2025
Study Completion
March 15, 2025
Last Updated
June 14, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Within 1 year of study completion
- Access Criteria
- Access to UVA Health portals, including UVA Health REDCap
IPD that underlie results in a publication.